Marshall Mohr Sells 6,000 Shares of Intuitive Surgical, Inc. (ISRG) Stock
Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Marshall Mohr sold 6,000 shares of the stock in a transaction on Monday, October 30th. The stock was sold at an average price of $372.22, for a total value of $2,233,320.00. Following the transaction, the chief financial officer now owns 12,316 shares of the company’s stock, valued at $4,584,261.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Shares of Intuitive Surgical, Inc. (ISRG) traded down 0.19% during mid-day trading on Tuesday, hitting $375.36. The stock had a trading volume of 841,722 shares. Intuitive Surgical, Inc. has a 52 week low of $203.57 and a 52 week high of $1,094.55. The firm has a market cap of $41.83 billion, a PE ratio of 53.94 and a beta of 0.39. The stock has a 50 day moving average price of $355.63 and a 200 day moving average price of $319.46.
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 19th. The medical equipment provider reported $2.77 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.78. Intuitive Surgical had a return on equity of 18.20% and a net margin of 30.16%. The company had revenue of $806.10 million during the quarter, compared to analysts’ expectations of $753.25 million. During the same quarter in the previous year, the firm earned $2.06 EPS. Intuitive Surgical’s revenue was up 18.0% on a year-over-year basis. Equities research analysts expect that Intuitive Surgical, Inc. will post $8.67 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This news story was posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright & trademark laws. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/31/marshall-mohr-sells-6000-shares-of-intuitive-surgical-inc-isrg-stock.html.
Several institutional investors have recently bought and sold shares of the company. Dimensional Fund Advisors LP increased its holdings in Intuitive Surgical by 1.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 64,691 shares of the medical equipment provider’s stock worth $49,583,000 after purchasing an additional 735 shares in the last quarter. Oppenheimer Asset Management Inc. acquired a new position in Intuitive Surgical in the 1st quarter worth about $190,000. Simonbaker & Partners LLC acquired a new position in Intuitive Surgical in the 1st quarter worth about $218,000. Tudor Investment Corp ET AL increased its holdings in Intuitive Surgical by 1,196.7% in the 1st quarter. Tudor Investment Corp ET AL now owns 15,664 shares of the medical equipment provider’s stock worth $12,006,000 after purchasing an additional 14,456 shares in the last quarter. Finally, Credit Suisse AG increased its holdings in Intuitive Surgical by 12.1% in the 1st quarter. Credit Suisse AG now owns 111,246 shares of the medical equipment provider’s stock worth $85,268,000 after purchasing an additional 11,965 shares in the last quarter. 31.40% of the stock is owned by institutional investors.
ISRG has been the subject of several recent analyst reports. Leerink Swann reiterated an “outperform” rating on shares of Intuitive Surgical in a research note on Wednesday, July 5th. Canaccord Genuity reiterated a “hold” rating and set a $96.67 price objective on shares of Intuitive Surgical in a research note on Tuesday, July 11th. Wells Fargo & Company reiterated an “outperform” rating and set a $116.67 price objective (up from $111.11) on shares of Intuitive Surgical in a research note on Wednesday, July 12th. Royal Bank Of Canada increased their price objective on Intuitive Surgical from $88.89 to $105.56 and gave the stock a “sector perform” rating in a research note on Tuesday, July 18th. Finally, Vetr lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $112.28 price objective for the company. in a research note on Thursday, July 20th. Five equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $154.72.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.